Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Aug 30, 2024 7:41am
352 Views
Post# 36202442

🌟 Greetings from the ESC Congress in London! 🇬🇧

🌟 Greetings from the ESC Congress in London! 🇬🇧Hugh MacNaught (Wednesday 28)This afternoon I am travelling to London for introductory meetings with potential collaborators and industry partners who are attending the 2024 ESC Congress. Rather than exhibiting at this year's congress we have arranged meetings to discuss specific opportunities and initiatives. With the introduction of magnet-free sensors, recent Health Canada Medical Device License for VMS+ V4.0 and approval/clearance pending in other key markets we are actively pursuing opportunities to deploy our products.



Greetings from the ESC Congress in London!

We're thrilled to be immersed in the heart of cardiology innovation at this year's hashtagESCCongressIt’s inspiring to connect with leading experts and dive into the latest advancements in heart health.

Here’s a snapshot from the event! 

Stay tuned for more updates as we continue to explore groundbreaking research and developments in cardiovascular care.

hashtagAngioConsult hashtagCardiology hashtagHeartHealth hashtagInnovation hashtagESCCongress2024
Greetings from the ESC Congress in London!

We're thrilled to be immersed in the heart of cardiology innovation at this year's hashtagESCCongressIt’s inspiring to connect with leading experts and dive into the latest advancements in heart health.

Here’s a snapshot from the event! 

Stay tuned for more updates as we continue to explore groundbreaking research and developments in cardiovascular care.

hashtagAngioConsult hashtagCardiology hashtagHeartHealth hashtagInnovation hashtagESCCongress2024

<< Previous
Bullboard Posts
Next >>